Ignite Creation Date:
2025-12-24 @ 4:22 PM
Ignite Modification Date:
2026-01-13 @ 7:33 PM
Study NCT ID:
NCT03917966
Status:
UNKNOWN
Last Update Posted:
2022-03-04
First Post:
2019-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-14
First Submit QC Date:
None
Study First Post Date:
2019-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-16
Last Update Post Date:
2022-03-04
Last Update Post Date Type:
ACTUAL